Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherMI Focus

Molecular Imaging of Ovarian Cancer

Sai Kiran Sharma, Brandon Nemieboka, Evis Sala, Jason S. Lewis and Brian Matthew Zeglis
Journal of Nuclear Medicine April 2016, jnumed.115.172023; DOI: https://doi.org/10.2967/jnumed.115.172023
Sai Kiran Sharma
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brandon Nemieboka
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evis Sala
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason S. Lewis
1 Memorial Sloan Kettering Cancer Center, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Matthew Zeglis
2 Hunter College of the City University of New York, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Ovarian cancer is the most lethal gynecologic malignancy and the fifth leading cause of cancer-related deaths in women. Over the past decade, medical imaging has played an increasingly valuable role in the diagnosis, staging, and treatment planning of the disease. In this Molecular Imaging Focus review, we seek to provide a brief yet informative survey of the current state of the molecular imaging of ovarian cancer. The article is divided into sections according to modality, covering recent advances in the magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT), ultrasound imaging (US), and optical imaging (OI) of ovarian cancer. While primary emphasis is given to clinical studies, particularly innovative and promising preclinical investigations are discussed as well. Ultimately, we are hopeful that the combination of technological innovations, novel imaging probes, and the further integration of imaging into clinical protocols will lead to significant improvements in the survival rates for ovarian cancer.

  • Molecular Imaging
  • Oncology: GYN
  • Radiopharmaceuticals
  • Magnetic Resonance Imaging
  • Molecular Imaging
  • Ovarian Cancer
  • Positron Emission Tomography
  • Single Photon Emission Computer Tomography
  • Copyright © 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Next
Back to top

In this issue

Journal of Nuclear Medicine: 66 (6)
Journal of Nuclear Medicine
Vol. 66, Issue 6
June 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Molecular Imaging of Ovarian Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Molecular Imaging of Ovarian Cancer
Sai Kiran Sharma, Brandon Nemieboka, Evis Sala, Jason S. Lewis, Brian Matthew Zeglis
Journal of Nuclear Medicine Apr 2016, jnumed.115.172023; DOI: 10.2967/jnumed.115.172023

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Molecular Imaging of Ovarian Cancer
Sai Kiran Sharma, Brandon Nemieboka, Evis Sala, Jason S. Lewis, Brian Matthew Zeglis
Journal of Nuclear Medicine Apr 2016, jnumed.115.172023; DOI: 10.2967/jnumed.115.172023
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Can fluorescence-guided surgery improve optimal surgical treatment for ovarian cancer? A systematic scoping review of clinical studies
  • Can fluorescence-guided surgery improve optimal surgical treatment for ovarian cancer? A systematic scoping review of clinical studies
  • Google Scholar

Similar Articles

Keywords

  • molecular imaging
  • Oncology: GYN
  • radiopharmaceuticals
  • magnetic resonance imaging
  • ovarian cancer
  • positron emission tomography
  • Single Photon Emission Computer Tomography
SNMMI

© 2025 SNMMI

Powered by HighWire